Quality use of medicines in the community: the Australian experience.
作者信息
Smith A J, McGettigan P
机构信息
Discipline of Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Newcastle, NSW 2298 Australia.
出版信息
Br J Clin Pharmacol. 2000 Dec;50(6):515-9. doi: 10.1046/j.1365-2125.2000.00291.x.
Abstract
摘要
相似文献
1
Quality use of medicines in the community: the Australian experience.社区药物的合理使用：澳大利亚的经验
Br J Clin Pharmacol. 2000 Dec;50(6):515-9. doi: 10.1046/j.1365-2125.2000.00291.x.
2
Copayments for medicines. How much should patients pay?药品自付费用。患者应支付多少？
Pharmacoeconomics. 1994 Sep;6(3):187-92. doi: 10.2165/00019053-199406030-00001.
3
Cost-effectiveness guidelines. The experience of Australian manufacturers.成本效益指南。澳大利亚制造商的经验。
Pharmacoeconomics. 1995 Nov;8(5):369-73. doi: 10.2165/00019053-199508050-00001.
4
Drugmakers exit the comfort zone.制药商走出舒适区。
State Health Care Am. 2001:24-6.
5
Higher profile puts them in the crosshairs.更高的知名度使他们成为众矢之的。
Manag Care. 2016 Dec;25(12):28-29.
6
Pharmacoeconomics: basic concepts and terminology.药物经济学：基本概念与术语
Br J Clin Pharmacol. 1997 Apr;43(4):343-8. doi: 10.1046/j.1365-2125.1997.00574.x.
7
Promoting cost effective prescribing.推广具有成本效益的处方开具。
BMJ. 1995 Apr 15;310(6985):955-6. doi: 10.1136/bmj.310.6985.955.
8
Generic versus brand name drugs in psychopharmacology: a pharmacoeconomic perspective.精神药理学中的通用名药物与品牌名药物：药物经济学视角
South Med J. 2011 Oct;104(10):715-6. doi: 10.1097/SMJ.0b013e31822cf201.
9
[Cost-effective drug utilization--what can the national drug agency do?].[具有成本效益的药物利用——国家药品机构能做什么？]
Tidsskr Nor Laegeforen. 2001 Aug 10;121(18):2207.
10
Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme.药品价格与性价比：澳大利亚药品福利计划
JAMA. 2005 Nov 23;294(20):2630-2. doi: 10.1001/jama.294.20.2630.
引用本文的文献
1
Consumers' knowledge and experiences of adverse drug reaction reporting in Australia: a national survey.消费者对澳大利亚药物不良反应报告的了解和经验：一项全国性调查。
Eur J Clin Pharmacol. 2024 Oct;80(10):1543-1554. doi: 10.1007/s00228-024-03729-y. Epub 2024 Jul 12.
2
Evaluation of the implementation outcomes of the Essential Medicines System in Anhui county-level public hospitals: a before-and-after study.安徽省县级公立医院基本药物制度实施效果评价：一项前后对照研究。
BMC Health Serv Res. 2015 Sep 22;15:403. doi: 10.1186/s12913-015-1073-z.
3
Development and validation of an instrument to assess the prescribing readiness of medical students in Malaysia.用于评估马来西亚医学生处方准备情况的工具的开发与验证。
BMC Med Educ. 2015 Sep 21;15:153. doi: 10.1186/s12909-015-0433-z.
4
An Australian perspective.一个澳大利亚人的视角。
Br J Clin Pharmacol. 2012 Jun;73(6):939-42. doi: 10.1111/j.1365-2125.2012.04242.x.
5
Public views on priority setting for high cost medications in public hospitals in Australia.澳大利亚公众对公立医院高成本药物的优先排序看法。
Health Expect. 2007 Sep;10(3):224-35. doi: 10.1111/j.1369-7625.2007.00439.x.
6
Construction and evaluation of a web-based interactive prescribing curriculum for senior medical students.面向高年级医学生的基于网络的交互式处方课程的构建与评估
Br J Clin Pharmacol. 2006 Dec;62(6):653-9. doi: 10.1111/j.1365-2125.2006.02651.x.
7
Quality use of medicines in aged-care facilities in Australia.澳大利亚老年护理机构中药物的合理使用。
Drugs Aging. 2003;20(9):643-53. doi: 10.2165/00002512-200320090-00002.
本文引用的文献
1
Pharmacoeconomics and policy decisions: the Australian health care system.药物经济学与政策决策：澳大利亚医疗保健系统
Clin Ther. 1999 May;21(5):909-15. doi: 10.1016/s0149-2918(99)80012-5.
2
Economic evaluation techniques in healthcare. Reinventing the wheel?医疗保健中的经济评估技术。是在 reinventing the wheel 吗？ （注：“reinventing the wheel”直译为“重新发明轮子”，意译为“多此一举” ，这里保留英文是因为在中文语境下直接意译可能会失去原文的一些韵味，具体使用哪种方式可根据实际需求调整 ）
Pharmacoeconomics. 1997 Feb;11(2):115-8. doi: 10.2165/00019053-199711020-00001.
3
Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia.澳大利亚反馈对全科医生处方影响的随机对照试验。
BMJ. 1999 Feb 20;318(7182):507-11. doi: 10.1136/bmj.318.7182.507.
4
Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group.医学文献用户指南。十三。如何使用一篇关于临床实践经济分析的文章。A.研究结果是否有效？循证医学工作组。
JAMA. 1997 May 21;277(19):1552-7. doi: 10.1001/jama.277.19.1552.
5
Update and evaluation of Australian guidelines. Government perspective.澳大利亚指南的更新与评估。政府视角。
Med Care. 1996 Dec;34(12 Suppl):DS216-25.
6
Principles of educational outreach ('academic detailing') to improve clinical decision making.改善临床决策的教育推广（“学术详情介绍”）原则。
JAMA. 1990 Jan 26;263(4):549-56.
7
Basing prescription drug payment on economic analysis: the case of Australia.基于经济分析的处方药支付：以澳大利亚为例。
Health Aff (Millwood). 1992 Winter;11(4):191-6. doi: 10.1377/hlthaff.11.4.191.
Zotero 插件